Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2004-01-20
2009-10-27
Hayes, Robert C (Department: 1649)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C562S453000, C530S399000
Reexamination Certificate
active
07608585
ABSTRACT:
Disclosed is a method for inhibition of necrosis induced by neurotrophin, and more specifically a method for inhibition of necrosis by administrating oxidative stress inhibitor and a method for simultaneous inhibition of necrosis and apoptosis by administrating oxidative stress inhibitor and neurotrophin. The oxidative stress inhibitor of the present invention can inhibit nerve cell necrosis induced by neurotrophin. Moreover, it can be used for protecting nerve cell damage connected with alzheimer disease, parkinson's disease, degenerating cerebropathia and promoting regeneration of the nerve cells by administrating oxidative stress inhibitor and neurotrophin.
REFERENCES:
patent: 5762922 (1998-06-01), Noble et al.
patent: WO 95/22342 (1995-08-01), None
patent: WO 01/79153 (2001-10-01), None
Iacovitti 1999. Brain Research 816:276-285.
Mattson, M.P. et al., “Mechanisms of Neurotrophic Factor Protection against Calsium- and Free Radical-Mediated Excitotoxic Injury: Implication for Treating Neurodegenerative Disorders,”Experimental Neurology 124(1):89-95, 1993.
Yaqub, B.A., “New Horizons in management of Alzheimer's disease,”Saudi Medical Journal 20(9): 671-677, 1999.
Alcántara, S. et al., “TrkB Signaling Is Required for Postnatal Survival of CNS Neurons and Protects Hippocampal and Motor Neurons from Axotomy-Induced Cell Death,”The Journal of Neuroscience 17(10): 3623-3633, May 15, 1997.
Apfel, S.C., “Neurotrophic Factor Therapy—Prospects and Problems,”Clinical Chemistry and Laboratory Medicine 39(4): 351-355 2001.
Bates, B. et al., “Neurotrophin-3 Promotes Cell Death Induced in Cerebral Ischemia, Oxygen-Glucose Deprivation, and Oxidative Stress: Possible Involvement of Oxygen Free Radicals,”Neurobiology of Disease 9: 24-37, 2002.
Borasio, G.D. et al., “Involvement of ras p21 in Neurotrophin-induced Response of Sensory by Not Sympathetic Neurons,”The Journal of Cell Biology 121(3): 665-672, May 1993.
Bowling, A.C. et al., “Superoxide Dismutase Activity, Oxidative Damage, and Mitochondrial Energy Metabolism in Familial and Sporadic Amyotophic Lateral Sclerosis,”Journal of Neurochemistry 61(6): 2322-2325, Dec. 1993.
Bradford, H.F. et al., “Neurotrophins in the Pathogenesis and Potential Treatment of Parkinson's Disease,”Advances in Neurology 80: 19-25, 1999.
Brown S.A. et al., “Role of oxygen-derived free radicals in the pathogenesis of shock and trauma, with focus on central nervous system injuries,”Journal of the American Veterinary Medical Association 200(12): 1849-1859, Jun. 15, 1992.
Deshmukh, M. et al., “Programmed Cell Death in Neurons: Focus on the Pathway of Nerve Growth Factor Deprivation-Induced Death of Sympathetic Neurons,”Molecular Pharmacology 51: 897-906, 1997.
Fernández-Sánchez, M.T. et al., “Basic fibroblast growth factor protects cerebellar neurons in primary culture from NMDA and non-NMDA receptor mediated neurotoxicity,”FEBS Letters 335(1): 124-131, Nov. 1993.
Ferrer, I. et al., “Brain-derived neurotophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat,”Neuropathologica 101(3): 229-238, 2001.
Friedman, B. et al., “BDNF and NT-4/5 Exert Neurotrophic Influences on Injured Adult Spinal Motor Neurons,”The Journal of Neuroscience 15(2): 1044-1056, Feb. 1995.
Frim, D.M. et al., “Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methy-4-phenylpyridinium toxicity to dopaminergic neurons in the rat,”Proc. Natl. Acad. Sci. USA 91: 5104-5108, May 1994.
Gash, D.M. et al., “Functional recovery in parkinsonian monkeys treated with GDNF,”Nature 380: 252-255, Mar. 21, 1996.
Gwag, B.J. et al., “BDNF or IGF-1 potentiates free radical-mediated injury in cortical cell cultures,”Neuroreport 7: 93-96, 1995.
Hall, E.D. et al., “Nonsteroidal Lazaroid U7851F in Models of Focal and Global Ischemia,”Stroke 21(11 Suppl. III): III83-III87, Nov. 1990.
He, Y. et al., “6-Hydroxydopamine induced apoptosis of dopaminergic cells in the rat substantia nigra,”Brain Research 858: 163-166, Mar. 2000.
Hefti, F., “Nerve Growth Factor Promotes Survival of Septal Cholinergic Neurons After Fimbrial Transections,”The Journal of Neuroscience 6(8): 2155-2162, Aug. 1986.
Hetman, M. et al., “Neuroprotection by Brain-derived Neurotrophic Factor Is Mediated by Extracellular Sing-regulated Kinase and Phosphatidylinositol 3-Kinase,”The Journal of Biological Chemistry 274(32): 22569-22580, Aug. 6, 1999.
Holtzman, D.M. et al., “Nerve Growth Factor Protects the Neonatal Brain Against Hypoxic—Ischemic Injury,”Annals of Neurology 39(1): 114-122, Jan. 1996.
Hwang, J.-J. et al., “The role of NADPH oxidase, neuronal nitric oxide synthase and poly(ADP ribose) polymerase in oxidative neuronal death induced in cortical cultures by brain-derived neurotrophic factor and neurotrophin-4/5,”Journal of Neurochemistry 82: 894-902, 2002.
Jin, Y. et al., “Transplants of Fibroblasts Genetically Modified to Express BDNF Promote Axonal Regeneration from Supraspinal Neurons Following Chronic Spinal Cord Injury,”Experimental Neurology 177: 265-275, 2002.
Juurlink, B.H.J. et al., “Review of Oxidative Stress in Brain and Spinal Cord Injury: Suggestions for Pharmacological and Nutritional Management Strategies,”Journal of Spinal Cord Medicine 21(4): 309-334, Oct. 1998.
Kim, S.H. et al., “Brain-derived neurotrophic factor can act as a pronecrotic factor through transcriptional and translational activation of NADPH oxidase,”The Journal of Cellular Biology 159(5): 821-831, Dec. 9, 2002.
Ko, M-L. et al., “The Combined Effect of Brain-Derived Neurotrophic Factor and a Free Radical Scavenger in Experimental Glaucoma,”Investigative Ophthalmology&Visual Science 41(10): 2967-2971, Sep. 2000.
Koh, J-Y. et al., “Potentiated Necrosis of Cultured Cortical Neurons by Neurotrophins,”Science 268: 573-575, Apr. 28, 1995.
Levi-Montalcini, R., “The Nerve Growth Factor: thirty-five years later,”The EMBO Journal 6(5): 1145-1154, 1987.
Levivier, M. et al., “Intrastriatal Implantation of Fibroblasts Genetically Engineered to Produced Brain-Derived Neurotrophic Factor Prevents Degeneration of Dopaminergic Neurons in a Rat Model of Parkinson's Disease,”The Journal of Neuroscience 15(12): 7810-7820, Dec. 1995.
Lewis, G.P. et al., “Effects of the Neurotrophic Brain-Derived Neurotrophic Factor in an Experimental Model of Retinal Detachment,”Investigative Ophthalmology&Visual Science 40(7): 1530-1544, Jun. 1999.
Lobner, D. et al., “Neutrotrophic Factor Effects on Oxidative Stress—Induced Neuronal Death,”Neurochemical Research 28(5): 749-756, May 2003.
Louvel, E. et al., “Therapeutic advances in amyotrophic lateral sclerosis,”Trends in Pharmacological Sciences 18: 196-203, Jun. 1997.
Lovell, M.A. et al., “Copper, iron and zinc in Alzheimer's disease senile plaques,”Journal of the Neurological Sciences 158: 47-52, 1998.
Montine, T.J. et al., “Crosslinking of Apolipoprotein E by Products of Lipid Peroxidation,”Journal of Neuropathology and Experimental Neurology 55: 202-210, Feb. 1996.
Morse, J. K. et al., “Brain-derived Neurotrophic Factor (BDNF) Prevents the Degeneration of Medial Septal Cholinergic Neurons Following Fimbria Transection,”The Journal of Neuroscience 13(10): 4146-4156, Oct. 1993.
Olson, L., “Toward trophic treatment in parkinsonism: A primate step,”Nature Medicine 2(4): 400-401, Apr. 1996.
Pérez-Navarro, E. et al., “Brain-Derived Neurotrophic Factor, Neurotrophin-3, and Neurotrophin-4/5 Prevent the Death of Striatal Projection Neurons in a Rodent Model of Huntingtons's Disease,”Journal of Neurochemi
Gwag Byoung Joo
Kim Sun-Hee
Won Seok-Joon
Yoon Sung-Hwa
Hayes Robert C
Neurotech Pharmaceuticals Co., Ltd.
Seed IP Law Group PLLC
LandOfFree
Compositions for inhibition of necrosis induced by a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for inhibition of necrosis induced by a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for inhibition of necrosis induced by a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4080307